Laboratory-confirmed DR, pre-XDR, and XDR-TB cases reported in the Free State, South Africa, from 2019 to 2022, according to previous and updated WHO definitions

Introduction: The global challenge of Tuberculosis (TB) control persists, particularly in addressing drug-resistant (DR) TB across regions. Over time, the rise in rifampicin (RIF/R) resistance, multi-drug resistant TB (MDR-TB, characterised until 2022 by RIF and Isoniazid (INH) resistance), pre-exte...

Full description

Saved in:
Bibliographic Details
Main Authors: Miss Zothile Skosana, Miss Likhona Dingiswayo, Mrs Anneke Van Der Spoel Van Dijk
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971224007239
Tags: Add Tag
No Tags, Be the first to tag this record!